CrowdStrike Holdings, Inc. (CRWD) stock
CRWDNasdaqServices-Prepackaged SoftwareFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Aug 27, 2026Score 12/30
$219.58−3.63 (-1.63%)
Close on Nov 17, 2026Market cap $224.84BP/E 3513.3Yield –
CrowdStrike r&d expenses
Research and development expenses are spending on new products and technology.
CrowdStrike's R&D Expenses for the twelve months ending Jul 31, 2026 was $1.56B, up 23.2% year over year. For fiscal 2026 it was $1.38B, up 28.7% from the year before. The highest annual figure on record is $1.38B in fiscal 2026.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $1.38B | +28.7% |
| FY2025 | Jan 31, 2025 | $1.08B | +37.8% |
| FY2024 | Jan 31, 2024 | $780.32M | +28.3% |
| FY2023 | Jan 31, 2023 | $608.36M | +63.9% |
| FY2022 | Jan 31, 2022 | $371.28M | +73.0% |
| FY2021 | Jan 31, 2021 | $214.67M | +64.9% |
| FY2020 | Jan 31, 2020 | $130.19M | +54.0% |
| FY2019 | Jan 31, 2019 | $84.55M | +43.6% |
| FY2018 | Jan 31, 2018 | $58.89M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | $444.20M | +29.7% |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | $408.33M | +23.4% |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | $356.41M | +13.6% |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | $347.56M | +26.1% |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | $342.53M | +36.5% |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | $330.93M | +40.7% |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | $313.83M | +39.0% |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | $275.60M | +40.6% |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | $250.91M | +39.9% |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | $235.25M | +31.4% |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | $225.82M | +17.7% |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | $196.07M | +26.3% |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | $179.36M | +30.1% |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | $179.07M | +45.1% |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | $191.85M | +82.7% |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | $155.26M | +59.0% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | $137.86M | +52.4% |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | $123.40M | +57.8% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | $105.02M | +58.9% |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | $97.63M | +69.7% |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | $90.46M | +79.2% |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | $78.18M | +92.7% |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | $66.07M | +70.8% |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $57.54M | +59.9% |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | $50.48M | +59.6% |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | $40.58M | +70.0% |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | $38.69M | +75.8% |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | $35.99M | +38.6% |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | $31.63M | +66.8% |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | $23.88M | +35.5% |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | $22.01M | – |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | $25.97M | – |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | $18.96M | – |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | $17.62M | – |
See a number that looks wrong?